65 related articles for article (PubMed ID: 9730050)
1. Effect of terguride on insulin binding, insulinaemia, glucose tolerance and hyperlipaemia in lean SHR Koletsky rats.
Golda V; Hilgertová J
Physiol Res; 1997; 46(6):439-42. PubMed ID: 9730050
[TBL] [Abstract][Full Text] [Related]
2. Effect of long lasting terguride treatment on mutual relationship between glycide and lipid parameters in SHR/N-cp Koletsky rats.
Golda V; Hilgertová J
Acta Medica (Hradec Kralove); 1998; 41(1):13-7. PubMed ID: 9588067
[TBL] [Abstract][Full Text] [Related]
3. Terguride but not bromocriptine alleviated glucose tolerance abnormalities and hyperlipidaemia in obese and lean genetically hypertensive Koletsky rats.
Golda V; Cvak L
Physiol Res; 1994; 43(5):299-305. PubMed ID: 7711008
[TBL] [Abstract][Full Text] [Related]
4. Ambivalent effect of long lasting terguride treatment on genetically based glycide and lipid metabolism abnormalities in SHR/N-cp Koletsky rats.
Golda V
Acta Medica (Hradec Kralove); 1998; 41(2):81-5. PubMed ID: 9729641
[TBL] [Abstract][Full Text] [Related]
5. Multiple regression analysis of parameters of lipid and glycide metabolism in obese and lean genetically hypertensive Koletsky rats under long lasting terguride treatment.
Golda V; Hilgertová J
Acta Medica (Hradec Kralove); 1996; 39(4):141-7. PubMed ID: 9270120
[TBL] [Abstract][Full Text] [Related]
6. Hyperprolactinemia in obese as well as in lean females of Koletsky rats: effect of long lasting terguride treatment.
Golda V; Jurcovicová J
Acta Medica (Hradec Kralove); 1998; 41(4):159-62. PubMed ID: 9951046
[TBL] [Abstract][Full Text] [Related]
7. Muscle GLUT-4 and insulin binding to erythrocytes and to adipose, liver and muscle tissue in genetically hypertensive obese rats and in their lean siblings: effect of long lasting terguride treatment.
Golda V; Hilgertová J; Zórad S
Acta Medica (Hradec Kralove); 1998; 41(3):125-30. PubMed ID: 9919714
[TBL] [Abstract][Full Text] [Related]
8. Effects of terguride treatment on glucose abnormalities induced by ischemic brain damage in SHR/N-cp lean Koletsky strain and in rats of Wistar strain.
Kudlackova Z; Golda V
Bratisl Lek Listy; 2004; 105(10-11):353-8. PubMed ID: 15658573
[TBL] [Abstract][Full Text] [Related]
9. Glucose intolerance induced by oligemic brain hypoxia: the effect of terguride.
Golda V; Hilgertová J
Acta Medica (Hradec Kralove); 1997; 40(3):57-60. PubMed ID: 9465428
[TBL] [Abstract][Full Text] [Related]
10. Effect of dehydroepiandrosterone on lipemia, glucose tolerance, insulinemia, insulin binding to erythrocytes in SHR/N-cp lean rats of Koletsky type.
Golda V; Hilgertová J
Acta Medica (Hradec Kralove); 1997; 40(2):31-5. PubMed ID: 9389208
[TBL] [Abstract][Full Text] [Related]
11. Terguride attenuates prolactin levels and ameliorates insulin sensitivity and insulin binding in obese spontaneously hypertensive rats.
Golda V; Ficková M; Pinterova L; Jurcovicová J; Macho L; Zórad S
Physiol Res; 2001; 50(2):175-82. PubMed ID: 11522045
[TBL] [Abstract][Full Text] [Related]
12. Terguride treatment attenuated prolactin release and enhanced insulin receptor affinity and GLUT 4 content in obese spontaneously hypertensive female, but not male rats.
Zorad S; Golda V; Fickova M; Macho L; Pinterova L; Jurcovicova J
Ann N Y Acad Sci; 2002 Jun; 967():490-9. PubMed ID: 12079879
[TBL] [Abstract][Full Text] [Related]
13. Development of lipid and glycide abnormalities in genetically hypertensive obese Koletsky rats and in their lean siblings.
Golda V; Hilgertová J
Acta Medica (Hradec Kralove); 1998; 41(4):163-6. PubMed ID: 9951047
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic actions of an insulin receptor activator and a novel peroxisome proliferator-activated receptor gamma agonist in the spontaneously hypertensive obese rat model of metabolic syndrome X.
Velliquette RA; Friedman JE; Shao J; Zhang BB; Ernsberger P
J Pharmacol Exp Ther; 2005 Jul; 314(1):422-30. PubMed ID: 15833894
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat.
Pulvirenti L; Balducci C; Piercy M; Koob GF
J Pharmacol Exp Ther; 1998 Sep; 286(3):1231-8. PubMed ID: 9732383
[TBL] [Abstract][Full Text] [Related]
16. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
[TBL] [Abstract][Full Text] [Related]
17. The dopamine D(2) partial agonist and antagonist terguride decreases heroin self-administration on fixed- and progressive-ratio schedules.
Zhang D; Wang X; Xiang X; Chen H; Zhang J; Su Q; Hao W
Pharmacol Biochem Behav; 2010 Dec; 97(2):222-6. PubMed ID: 20705086
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of 2-bromoterguride at human dopamine D2, porcine serotonin 5-hydroxytryptamine 2A, and α2C-adrenergic receptors, and its antipsychotic-like effects in rats.
Jantschak F; Brosda J; Franke RT; Fink H; Möller D; Hübner H; Gmeiner P; Pertz HH
J Pharmacol Exp Ther; 2013 Oct; 347(1):57-68. PubMed ID: 23863695
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB).
Ernsberger P; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Friedman JE
J Pharmacol Exp Ther; 1999 Jan; 288(1):139-47. PubMed ID: 9862764
[TBL] [Abstract][Full Text] [Related]
20. Independence of estrogen-induced pituitary proliferation on local IGF-I mRNA and EGF mRNA expression. Modifying effects of tamoxifen and terguride.
Hána V; Haluzík M; Schreiber V
Physiol Res; 1998; 47(2):125-31. PubMed ID: 9706996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
